2014-77-9

Basic information

• Product Name: 1-(phenylthio)-2-aminopropane
• Synonyms: 1-(phenylthio)-2-aminopropane
• CAS NO: 2014-77-9
• Molecular Formula: C₉H₁₃NS
• Molecular Weight: 167.27
• Mol File: 2014-77-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 262.3°Cat760mmHg
• Flash Point: 112.4°C
• Appearance: /
• Density: 1.05g/cm³
• Vapor Pressure: 0.011mmHg at 25°C
• Refractive Index: 1.576
• CAS DataBase Reference: 1-(phenylthio)-2-aminopropane(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(phenylthio)-2-aminopropane(2014-77-9)
• EPA Substance Registry System: 1-(phenylthio)-2-aminopropane(2014-77-9)

Safety Data

• Hazardous Substances Data: 2014-77-9(Hazardous Substances Data)

Usage

Synthesis Reference(s)

The Journal of Organic Chemistry, 28, p. 2589, 1963 DOI: 10.1021/jo01045a025

InChI:InChI=1/C9H13NS/c1-8(10)7-11-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3

Upstream product

• 108-98-5 thiophenol 
• 75-55-8 2-Methylaziridine 
• 5042-53-5 1-(phenylsulfanyl)acetone 
• 27872-74-8 phenylmercaptopropanone oxime 
• 91281-29-7 N-[1-methyl-2-(phenylthio)ethyl]acetamide 

Downstream Products

• 958261-88-6 N-[(10-bromo-2,3,6-trimethoxyphenanthren-9-yl)methyl]-N-[1-methyl-2-(phenylsulfanyl)ethyl]amine 
• 958261-94-4 N-[1-methyl-2-(phenylsulfanyl)ethyl]-[9-bromo-2,3,6-trimethoxyphenanthren-10-yl]methylamine 
• 116143-19-2 7-Piperazinyl-6-fluoro-1-(2-(phenylsulfinyl)-1-methylethyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid ethyl ester 
• 116143-18-1 6-Fluoro-7-chloro-1-(2-(phenylsulfinyl)-1-methylethyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid ethyl ester 
• 22039-88-9 1-Phenylthio-2-propyl-isocyanat 
• 116143-17-0 7-Chloro-6-fluoro-1-(1-methyl-2-phenylsulfanyl-ethyl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester 

Relevant articles and documents

Sulfur, selenium and tellurium containing amines act as effective carbonic anhydrase activators

A new series of β-aminochalcogenides were designed and synthesized to identify new carbonic anhydrase activator (CAA) agents as novel tools for the management of several neurodegenerative and metabolic disorders which represent a clinical challenge withou

Synthesis of mexiletine analogues from non-activated aziridines

A general method for the synthesis of mexiletine analogues by nucleophilic ring opening of non-activated racemic aziridines has been developed (Scheme 1). Structural variation is introduced by employing different nucleophiles or by altering the substitution on the aziridine ring.